Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferritin heavy chain 1 pseudogene 22 (FTH1P22) is a pseudogene of the ferritin heavy chain gene family. Unlike the canonical ferritin heavy chain 1 gene (FTH1), it does not encode a functional protein. Pseudogenes like FTH1P22 may function as regulatory elements in gene expression, acting through RNA-mediated mechanisms such as competing endogenous RNA (ceRNA) or serving as sources for small interfering RNAs (siRNAs) that influence the expression of their parental gene. Although such pseudogenes have historically been considered non-functional, recent evidence indicates that some can regulate biological processes, including those relevant in cancer and cell metabolism, by interacting with the regulatory networks of their functional gene family members[3]. FTH1P22 itself has no known direct therapeutic, enzymatic, or receptor function and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 22 (FTH1P22).